Fidelity Investments
AVEO

Fidelity Investments’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Fidelity Investments’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-209
Closed -$3.13K – 5677
2022
Q4 		$3.13K Buy
+209
New +$2.89K ﹤0.01% 4396
2020
Q2 		– Sell
-450
Closed -$2K – 4454
2020
Q1 		$2K Buy
450
+250
+125% +$1.24K ﹤0.01% 3453
2019
Q4 		$1K Buy
200
+100
+100% +$736 ﹤0.01% 3730
2019
Q3 		$1K Buy
+100
New +$744 ﹤0.01% 3725
2014
Q1 		– Sell
-87,046
Closed -$1.6M – 2740
2013
Q4 		$1.6M Buy
87,046
+26,234
+43% +$525K ﹤0.01% 2392
2013
Q3 		$1.26M Buy
60,812
+22,526
+59% +$516K ﹤0.01% 2417
2013
Q2 		$957K Buy
+38,286
New +$1.64M ﹤0.01% 2422

Fidelity Investments's AVEO Position: Q1 2023 in Review

Fidelity Investments sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 209 shares — an estimated $3.13K sold.

Fidelity Investments first reported a position in AVEO in Q2 2013 and held it in 7 quarters. The position peaked at $1.6M in Q4 2013. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

  • Fidelity Investments reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Fidelity Investments sold 209 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $3.13K.
  • Fidelity Investments first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 7 quarters.
  • Fidelity Investments's AVEO Pharmaceuticals, Inc. position peaked at $1.6M in Q4 2013.
  • 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Fidelity Investments's 13F filing for Q1 2023, filed 11 May 2023.